These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13710710)

  • 1. Relation of eye signs in Graves' disease to circulating antibodies to thyroglobulin.
    HALES IB; MYHILL J; RUNDLE FF; MACKAY IR; PERRY B
    Lancet; 1961 Mar; 1(7175):468-9. PubMed ID: 13710710
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
    Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of thyroid auto-immunity to round-celled infiltration of the thyroid gland.
    SCHADE RO; OWEN SG; SMART GA; HALL R
    J Clin Pathol; 1960 Nov; 13(6):499-501. PubMed ID: 13747148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
    Balázs C
    Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-stimulating antibodies in patients with autoimmune disorders.
    Strakosch CR; Joyner D; Wall JR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle.
    Mullin BR; Levinson RE; Friedman A; Henson DE; Winand RJ; Kohn LD
    Endocrinology; 1977 Feb; 100(2):351-66. PubMed ID: 401730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid autoimmunity and thyroid autonomy.
    Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
    Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.
    Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A
    J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on the exophthalmos of Graves' disease.
    MCCULLAGH EP
    J Clin Endocrinol Metab; 1953 Jul; 13(7):818-24. PubMed ID: 13069590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graves' ophthalmopathy following external neck irradiation: evidence for immunologic pathogenesis (author's transl)].
    Wenzel KW; Schleusener H; Weise W
    Dtsch Med Wochenschr; 1974 Oct; 99(41):2036-9. PubMed ID: 4547699
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between unilateral exophthalmos and thyroid diseases.
    Cennamo G; Bizzarro A; Soricelli A; Dendi B; Bonavolontà G
    Ophthalmologica; 1980; 180(4):216-20. PubMed ID: 6777725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exophthalmos of Graves' disease: a summary of the present status of therapy.
    McCULLAGH EP; CLAMEN M; GARDNER WJ; KENNEDY RJ; LOCKHART G
    Ann Intern Med; 1958 Mar; 48(3):445-70. PubMed ID: 13521580
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of exophthalmus producing factor (EPF) in hyperthyroidism and its sensitization by carticotropin].
    Weisbecker L; Schemmel K; Sperber K; Kreysing G; Uthgenannt H
    Schweiz Med Wochenschr; 1969 Mar; 99(13):450-2. PubMed ID: 4306546
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual case of malignant exophthalmos and postoperative hypothyroidism complicating Graves' disease.
    ENGEL FL
    J Clin Endocrinol Metab; 1953 Sep; 13(9):1132-9. PubMed ID: 13084736
    [No Abstract]   [Full Text] [Related]  

  • 19. Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy.
    FURTH ED; BECKER DV; RAY BS; KANE JW
    J Clin Endocrinol Metab; 1962 May; 22():518-24. PubMed ID: 13895979
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of exophthalmos and related ocular changes in Graves' disease.
    RUNDLE FF
    Metabolism; 1957 Jan; 6(1):36-48. PubMed ID: 13386967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.